Jaguar Health (JAGX) Gains from Investment Securities (2014 - 2025)
Jaguar Health (JAGX) reported Gains from Investment Securities of -$134000.0 for Q3 2025, up 18.29% year-over-year from -$113278.4 in Q3 2024, and down 1207.44% quarter-over-quarter from $12100.0 in Q2 2025.
Jaguar Health (JAGX) Gains from Investment Securities (2014 - 2025) Analysis & Trends
Jaguar Health (JAGX) has 12 years of Gains from Investment Securities data on file, last reported at -$134000.0 in Q3 2025.
- Gains from Investment Securities for Q3 2025 came in at -$134000.0, up 18.29% year-over-year; the trailing twelve-month figure through Dec 2025 was -$300000.0 (up 69.85% YoY), and the FY2025 annual result was $5181.0, down 83.06% from the prior year.
- Gains from Investment Securities declined to -$134000.0 in Q3 2025 per JAGX's latest filing, from $12100.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $3.0 million in Q1 2022 and troughed at -$735000.0 in Q1 2024.
- A 5-year average of $681423.7 and a median of $12376.0 in 2023 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2022 and 2024: Gains from Investment Securities soared 16626.19% in 2022, then plunged 4183.33% in 2024.
- A 5-year view of Gains from Investment Securities shows it stood at $1.1 million in 2021, then sank by 87.51% to $142000.0 in 2022, then tumbled by 92.96% to $10000.0 in 2023, then sank by 120.0% to -$2000.0 in 2024, then plunged by 6600.0% to -$134000.0 in 2025.
- Business Quant data shows JAGX's Gains from Investment Securities at -$134000.0 in Q3 2025, $12100.0 in Q2 2025, and $3000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -134,000.00 |
| Sep 30, 2025 | -134,000.00 |
| Jun 30, 2025 | 12,100.00 |
| Jun 30, 2025 | 12,100.00 |
| Mar 31, 2025 | 3,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Sep 30, 2024 | -164,000.00 |
| Sep 30, 2024 | -164,000.00 |
| Jun 30, 2024 | -94,000.00 |
| Jun 30, 2024 | -94,000.00 |
| Mar 31, 2024 | -735,000.00 |
| Mar 31, 2024 | -735,000.00 |
| Dec 31, 2023 | 10,000.00 |
| Dec 31, 2023 | 10,000.00 |
| Sep 30, 2023 | 12,376.00 |
| Sep 30, 2023 | 12,376.00 |
| Jun 30, 2023 | 183,000.00 |
| Jun 30, 2023 | 183,000.00 |